Successful port-a-cath salvage using linezolid in children with acute leukemia

Pediatr Blood Cancer. 2013 Sep;60(9):E103-5. doi: 10.1002/pbc.24520. Epub 2013 Jun 15.

Abstract

Central venous catheter (CVC) removal is indicated when persistent catheter-related bloodstream infection (CRBSI) occurs. This is a retrospective study to analyze the use of linezolid as a salvage therapy for CRBSIs due to coagulase-negative Staphylococci in children diagnosed with acute leukemia. Seven treatment courses of linezolid were administrated to six patients with port-type-CRBSI after non-effective intravenous vancomycin or teicoplanin treatment. Simultaneous lock and systemic therapy with linezolid avoided the removal of port-type-CVC in all cases. Treatment with linezolid was an alternative to catheter removal in these patients. Prospective studies are needed to confirm linezolid effectiveness as a salvage treatment in CRBSI.

Keywords: acute leukemia; catheter-related infections; children; linezolid.

MeSH terms

  • Acetamides / administration & dosage*
  • Anti-Infective Agents / administration & dosage*
  • Central Venous Catheters*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / microbiology
  • Leukemia, Myeloid, Acute / pathology
  • Linezolid
  • Male
  • Oxazolidinones / administration & dosage*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / microbiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Retrospective Studies
  • Salvage Therapy
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus*

Substances

  • Acetamides
  • Anti-Infective Agents
  • Oxazolidinones
  • Linezolid